TITAN-X Trademark

Trademark Overview

On Monday, November 29, 2021, a trademark application was filed for TITAN-X with the United States Patent and Trademark Office. The USPTO has given the TITAN-X trademark a serial number of 97146751. The federal status of this trademark filing is REGISTERED as of Tuesday, May 21, 2024. This trademark is owned by NIMML Institute. The TITAN-X trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines; Research and development of vaccines and medicines
titan-x

General Information

Serial Number97146751
Word MarkTITAN-X
Filing DateMonday, November 29, 2021
Status700 - REGISTERED
Status DateTuesday, May 21, 2024
Registration Number7392301
Registration DateTuesday, May 21, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements

Pseudo MarkTITAN X
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Research and development of vaccines and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 2, 2021
Primary Code042
First Use Anywhere DateMonday, November 29, 2021
First Use In Commerce DateTuesday, June 20, 2023

Trademark Owner History

Party NameNIMML Institute
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060
Party NameNIMML Institute
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060
Party NameNIMML Institute
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060

Trademark Events

Event DateEvent Description
Thursday, September 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 2, 2021NEW APPLICATION ENTERED
Thursday, December 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 7, 2022ASSIGNED TO EXAMINER
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 20, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, June 20, 2023USE AMENDMENT FILED
Monday, July 17, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 27, 2023ASSIGNED TO EXAMINER
Friday, August 25, 2023SU - NON-FINAL ACTION - WRITTEN
Friday, August 25, 2023NON-FINAL ACTION E-MAILED
Friday, August 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 21, 2024ASSIGNED TO LIE
Wednesday, February 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 12, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, April 13, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 21, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 21, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

titan medicines development vaccines research preparations pharmaceutical